Resectable pancreatic cancer
Earlier detection, better assessment and new drug combinations provide cautious optimism for longer survival
Leyo Ruo, MD, FRCSC

Cancer cachexia
The benefits of routine screening to determine which patients require nutritional assessment
Nelda Swinton, PDt, OPDQ, DC, Martin R. Chasen, MBChB, FCP(SA), MPhil(Pall Med) and Neil MacDonald, CM, MD, FRCPC, FRCP(Edin)

Treatment of colorectal cancer
Report of the Eastern Canadian Colorectal Cancer Consensus
Conference Derek J. Jonker, MD, FRCPC et al

Distant metastases in breast cancer
Better survival depends on strategies for decreasing recurrence
Karen A. Gelmon, MD, FRCPC Funded by an educational grant from Novartis Pharmaceuticals Canada Inc.

Complementary and alternative medicine
Since so many patients use it, cancer care professionals should become informed
Anne Leis, PhD and Mark A. Ferro, MSc

Cover photo: Coloured SEM pancreatic cancer cell.S.GSCHMEISSNER/SPL/PUBLIPHOTO

Essential reading: research updates and commentaries
Review of important clinical trial data recently presented at the 42nd Annual Meeting of the American Society of Clinical Oncology
With commentaries by Nizar Bahlis, MD, Debjani Grenier, MD, FRCPC, John Hay, MD, MB BChir, FRCPC, FRCR, Christian Kollmannsberger, MD, Nevin Murray, MD, FRCPC, Denis Soulières, MD, MSc, FRCPC
Lung Cancer
Breast Cancer Prevention
Head and Neck Cancer
Gastric Cancer
Rectal Cancer
Multiple Myeloma

Reports from Canadian meetings
The 16th Annual Ontario Provincial Conference on Palliative and End-of-Life Care

RealTime Cancer
Support for the special needs of young adults with cancer
Rebecca Flood, BCom, Tara O’Brien, BBA, BA and Geoff Eaton, BBA

Professional meetings roster
Your calendar dates for essential conferences and symposia

New drugs and indications
A review of recent cancer therapy approvals in Canada and the U.S.